Nasdaq:US$16.48 (+0.12) | HKEX:HK$26.00 (-0.10) | AIM:£2.70 (-0.01)
新闻中心及演示文稿
上一篇文章   |   下一篇文章
演示文稿, 科学出版物 | 2011-04-06

AACR 2011: Savolitinib (HMPL-504) against subcutaneous xenograft and orthotopic brain tumor models